SlideShare una empresa de Scribd logo
1 de 4
Val in Crs
MAT MTH Val (Cr) MS% GR% Val (Cr) MS% GR% CORPORATE MAT MTH
76567 100.00 5.9 6636 100.00 8.1 IPM
1 1 4893 6.39 3.8 414 6.44 4.8 Abbott + Abbott HC + Novo `1 1
2 2 4168 5.44 15.4 377 5.34 15.2 Sun Pharma 2 2
3 3 3809 4.97 6.2 326 4.97 6.8 Cipla `2 3
4 4 3363 4.39 6.3 281 4.39 4.3 Zydus + Biochem 3 4
5 6 2836 3.70 -3.6 233 3.98 -4.7 Ranbaxy `3 7
6 5 2727 3.56 5.4 243 3.50 13.3 Mankind `5 9
7 8 2710 3.54 -15.6 227 4.02 -7.8 Glaxo 4 6
8 9 2673 3.49 9.9 226 3.39 8.3 Alkem + Cachet + Indchemie 5 8
9 7 2581 3.37 11.7 230 3.36 11.7 Lupin `4 5
10 11 2226 2.91 3.0 189 2.95 4.0 Pfizer 6 11
11 12 2162 2.82 15.0 183 2.65 12.9 Emcure + Zuventus `6 12
12 10 2056 2.69 11.5 198 2.55 26.7 Macleods 7 10
13 13 1926 2.52 0.3 175 2.65 7.7 Sanofi `7 13
14 14 1909 2.49 7.0 168 2.55 7.4 Intas 8 14
15 15 1877 2.45 14.7 164 2.17 23.1 Aristo `8 15
16 18 1667 2.18 15.7 131 1.89 13.6 Glenmark 9 18
17 16 1635 2.14 5.7 144 2.16 8.9 Dr. Reddys `9 16
18 17 1572 2.05 9.3 139 2.15 5.7 Micro + Bal 10 17
19 21 1407 1.84 9.1 118 1.87 3.1 USV `10 21
20 19 1394 1.82 14.0 127 1.79 15.1 Torrent 11 19
21 20 1372 1.79 20.4 124 1.59 27.8 IPCA `11 20
22 22 1222 1.60 3.0 102 1.53 8.6 Wockhardt 12 22
23 23 1133 1.48 -1.3 94 1.55 -1.4 Novartis `12 23
24 24 1056 1.38 10.5 86 1.23 13.4 Alembic 13 24
25 25 812 1.06 2.3 72 1.13 2.8 FDC `13 25
26 27 793 1.04 8.2 70 0.98 16.1 Unichem 14 27
27 26 784 1.02 7.7 70 0.95 19.6 MSD + Fulford + Organon `14 26
28 28 616 0.80 11.4 55 0.83 7.7 Cadila 15 28
29 29 592 0.77 5.3 50 0.72 13.2 Indoco Remedies 16 30
30 31 567 0.74 11.6 48 0.69 13.5 Franco `16 31
31 30 566 0.74 24.1 50 0.72 13.4 Eris `15 29
32 32 470 0.61 3.0 44 0.63 14.1 Himalaya 17 32
33 34 465 0.61 8.9 42 0.60 13.9 Merck `17 34
34 43 429 0.56 -41.4 30 0.97 -49.8 Elder 18 42
35 37 423 0.55 1.5 35 0.50 14.2 Blue Cross `19 37
36 33 405 0.53 11.0 43 0.65 6.8 JB Chemicals 19 33
37 40 395 0.52 16.7 32 0.51 0.9 Astrazeneca `18 39
38 39 383 0.50 -10.7 32 0.65 -19.7 Bharat Serums 20 40
39 36 376 0.49 -1.0 35 0.54 5.5 Raptakos, Brett `20 35
40 35 372 0.49 21.0 35 0.45 27.5 Meyer Organics 21 36
41 38 361 0.47 7.8 33 0.46 16.8 Wallace + Indi Pharma `21 38
42 45 347 0.45 11.6 28 0.39 17.0 Hetero `23 51
With Bonus Units at Full Value Witho
Rank MAT May-14 May-14 Rank
43 42 333 0.43 7.6 30 0.44 10.4 Medley 23 43
44 44 330 0.43 0.6 29 0.45 3.3 Win-Medicare 22 44
45 41 318 0.41 33.4 31 0.33 54.1 Akumentis 24 41
46 48 317 0.41 10.8 27 0.41 8.1 Janssen `22 46
47 47 311 0.41 3.3 27 0.44 2.1 Albert David `24 47
48 50 293 0.38 47.9 26 0.30 44.8 Biocon 25 49
49 46 284 0.37 33.4 28 0.31 45.0 Ajanta `25 45
50 52 277 0.36 25.2 26 0.37 14.3 Hegde & Hegde 26 50
Val (Cr) MS% GR% Val (Cr) MS% GR%
73629 100.00 5.9 6397 100.00 8.7
4794 6.51 3.5 407 6.36 5.2
4073 5.53 14.4 370 5.78 15.2
3572 4.85 9.0 307 4.80 10.3
3143 4.27 6.1 264 4.12 5.7
2743 3.73 -3.6 225 3.52 -4.7
2306 3.13 6.9 208 3.25 16.9
2675 3.63 -14.9 226 3.53 -6.2
2483 3.37 9.7 212 3.31 10.0
2524 3.43 11.6 226 3.53 12.1
2176 2.95 3.3 185 2.89 4.6
2097 2.85 15.3 178 2.78 13.5
1927 2.62 11.2 186 2.90 26.8
1890 2.57 0.0 172 2.68 7.6
1884 2.56 6.4 166 2.60 7.7
1654 2.25 11.9 143 2.23 20.5
1619 2.20 15.3 128 2.00 13.4
1602 2.18 4.9 141 2.21 8.8
1503 2.04 9.9 134 2.09 6.3
1401 1.90 9.0 118 1.84 3.4
1370 1.86 13.8 124 1.94 14.5
1305 1.77 20.0 120 1.87 29.4
1197 1.63 2.7 100 1.56 8.7
1092 1.48 -0.6 91 1.42 0.4
1023 1.39 11.0 83 1.30 14.3
790 1.07 2.2 69 1.08 3.2
776 1.05 7.5 68 1.06 16.1
774 1.05 7.6 69 1.07 18.8
594 0.81 11.2 53 0.83 7.6
551 0.75 5.6 47 0.73 13.4
546 0.74 11.0 46 0.72 13.3
563 0.76 23.9 50 0.77 13.3
468 0.64 2.6 44 0.68 13.8
454 0.62 7.5 41 0.64 12.6
413 0.56 -39.8 29 0.46 -47.7
389 0.53 3.5 32 0.50 13.5
389 0.53 10.8 41 0.64 6.1
391 0.53 15.8 31 0.49 0.5
375 0.51 -11.2 31 0.49 -19.9
371 0.50 -1.3 35 0.54 5.6
360 0.49 20.8 34 0.53 27.5
331 0.45 11.7 32 0.50 28.5
315 0.43 11.9 25 0.40 17.9
Without Bonus Units
MAT May -14 May-14
316 0.43 8.3 29 0.45 10.3
325 0.44 -0.6 28 0.44 1.7
311 0.42 35.4 31 0.48 54.7
317 0.43 10.7 27 0.43 8.1
305 0.41 3.2 27 0.42 1.9
292 0.40 47.9 26 0.41 44.7
282 0.38 33.3 27 0.43 44.9
276 0.38 25.2 26 0.40 14.3

Más contenido relacionado

La actualidad más candente

Louis Vuitton
Louis Vuitton Louis Vuitton
Louis Vuitton mindway
 
marketing & sales roles for the pharma industries
marketing & sales roles for the pharma industriesmarketing & sales roles for the pharma industries
marketing & sales roles for the pharma industriesAbhilash Vangari
 
Benadryl cough syrup
Benadryl cough syrupBenadryl cough syrup
Benadryl cough syrupPooja Awasthi
 
Q4 and Full Year Results 2021
Q4 and Full Year Results 2021Q4 and Full Year Results 2021
Q4 and Full Year Results 2021Sanofi
 
Report on MANAGEMENT PRACTICES IN BEXIMCO PHARMA
Report on MANAGEMENT PRACTICES IN BEXIMCO PHARMAReport on MANAGEMENT PRACTICES IN BEXIMCO PHARMA
Report on MANAGEMENT PRACTICES IN BEXIMCO PHARMAArif Hossain
 
Industrial training report
Industrial training reportIndustrial training report
Industrial training reportKishanPatel614
 
Opportunities & Challenges in West Africa's (Ghana & Nigeria) Healthcare and ...
Opportunities & Challenges in West Africa's (Ghana & Nigeria) Healthcare and ...Opportunities & Challenges in West Africa's (Ghana & Nigeria) Healthcare and ...
Opportunities & Challenges in West Africa's (Ghana & Nigeria) Healthcare and ...Aiswariya Chidambaram
 
Business Report on Pfizer
Business Report on PfizerBusiness Report on Pfizer
Business Report on PfizerAileen Marshall
 
FULL DETAIL OF SUN PHARMA & PHARMACEUTICAL INDUSTRY 2015
FULL DETAIL OF SUN PHARMA & PHARMACEUTICAL INDUSTRY 2015FULL DETAIL OF SUN PHARMA & PHARMACEUTICAL INDUSTRY 2015
FULL DETAIL OF SUN PHARMA & PHARMACEUTICAL INDUSTRY 2015Sabarinath Suryaprakash
 
M•A•C Cosmetics Advertising Campaign
M•A•C Cosmetics Advertising Campaign M•A•C Cosmetics Advertising Campaign
M•A•C Cosmetics Advertising Campaign Sarah Lombard
 
Marketing Plan for a new product in existing market
Marketing Plan for a new product in existing market Marketing Plan for a new product in existing market
Marketing Plan for a new product in existing market azamushahiullah prottoy
 
Project report marketing- abott
Project report  marketing- abottProject report  marketing- abott
Project report marketing- abottStudsPlanet.com
 
Pitch 2 helena zhao
Pitch 2  helena zhaoPitch 2  helena zhao
Pitch 2 helena zhaoHelenaZhao5
 
Pharmaceutical marketing plan case study
Pharmaceutical marketing plan case studyPharmaceutical marketing plan case study
Pharmaceutical marketing plan case studyMohamed Magdy
 
Sunsilk V/s Head&Shoulders FMCG
Sunsilk V/s Head&Shoulders FMCGSunsilk V/s Head&Shoulders FMCG
Sunsilk V/s Head&Shoulders FMCGOnlyurs
 

La actualidad más candente (20)

Louis Vuitton
Louis Vuitton Louis Vuitton
Louis Vuitton
 
marketing & sales roles for the pharma industries
marketing & sales roles for the pharma industriesmarketing & sales roles for the pharma industries
marketing & sales roles for the pharma industries
 
Benadryl cough syrup
Benadryl cough syrupBenadryl cough syrup
Benadryl cough syrup
 
Q4 and Full Year Results 2021
Q4 and Full Year Results 2021Q4 and Full Year Results 2021
Q4 and Full Year Results 2021
 
տետր
տետրտետր
տետր
 
Report on MANAGEMENT PRACTICES IN BEXIMCO PHARMA
Report on MANAGEMENT PRACTICES IN BEXIMCO PHARMAReport on MANAGEMENT PRACTICES IN BEXIMCO PHARMA
Report on MANAGEMENT PRACTICES IN BEXIMCO PHARMA
 
Pharma business models
Pharma business modelsPharma business models
Pharma business models
 
Industrial training report
Industrial training reportIndustrial training report
Industrial training report
 
Opportunities & Challenges in West Africa's (Ghana & Nigeria) Healthcare and ...
Opportunities & Challenges in West Africa's (Ghana & Nigeria) Healthcare and ...Opportunities & Challenges in West Africa's (Ghana & Nigeria) Healthcare and ...
Opportunities & Challenges in West Africa's (Ghana & Nigeria) Healthcare and ...
 
Body shop
Body shopBody shop
Body shop
 
Business Report on Pfizer
Business Report on PfizerBusiness Report on Pfizer
Business Report on Pfizer
 
Boots
BootsBoots
Boots
 
FULL DETAIL OF SUN PHARMA & PHARMACEUTICAL INDUSTRY 2015
FULL DETAIL OF SUN PHARMA & PHARMACEUTICAL INDUSTRY 2015FULL DETAIL OF SUN PHARMA & PHARMACEUTICAL INDUSTRY 2015
FULL DETAIL OF SUN PHARMA & PHARMACEUTICAL INDUSTRY 2015
 
Clinique 2012-final
Clinique 2012-finalClinique 2012-final
Clinique 2012-final
 
M•A•C Cosmetics Advertising Campaign
M•A•C Cosmetics Advertising Campaign M•A•C Cosmetics Advertising Campaign
M•A•C Cosmetics Advertising Campaign
 
Marketing Plan for a new product in existing market
Marketing Plan for a new product in existing market Marketing Plan for a new product in existing market
Marketing Plan for a new product in existing market
 
Project report marketing- abott
Project report  marketing- abottProject report  marketing- abott
Project report marketing- abott
 
Pitch 2 helena zhao
Pitch 2  helena zhaoPitch 2  helena zhao
Pitch 2 helena zhao
 
Pharmaceutical marketing plan case study
Pharmaceutical marketing plan case studyPharmaceutical marketing plan case study
Pharmaceutical marketing plan case study
 
Sunsilk V/s Head&Shoulders FMCG
Sunsilk V/s Head&Shoulders FMCGSunsilk V/s Head&Shoulders FMCG
Sunsilk V/s Head&Shoulders FMCG
 

Más de Anup Soans

An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...
An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...
An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...Anup Soans
 
Key Challenges Facing Pharma Industry and the Way Forward
Key Challenges Facing Pharma Industry and the Way ForwardKey Challenges Facing Pharma Industry and the Way Forward
Key Challenges Facing Pharma Industry and the Way ForwardAnup Soans
 
Trends in Pharma Marketing - Focus and Spending
Trends in Pharma Marketing - Focus and SpendingTrends in Pharma Marketing - Focus and Spending
Trends in Pharma Marketing - Focus and SpendingAnup Soans
 
MedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27th
MedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27thMedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27th
MedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27thAnup Soans
 
Key Account Management - Time for India Pharma to Adopt KAM
Key Account Management - Time for India Pharma to Adopt KAMKey Account Management - Time for India Pharma to Adopt KAM
Key Account Management - Time for India Pharma to Adopt KAMAnup Soans
 
MedicinMan Report on Digital Readiness of Indian Pharma 2021
MedicinMan Report on Digital Readiness of Indian Pharma 2021MedicinMan Report on Digital Readiness of Indian Pharma 2021
MedicinMan Report on Digital Readiness of Indian Pharma 2021Anup Soans
 
How can Pharma Use Digital to Engage Doctors and Understand Patients
How can Pharma Use Digital to Engage Doctors and Understand PatientsHow can Pharma Use Digital to Engage Doctors and Understand Patients
How can Pharma Use Digital to Engage Doctors and Understand PatientsAnup Soans
 
Why Indian Pharma Needs to Enable Managers to Develop Talent
Why Indian Pharma Needs to Enable Managers to Develop TalentWhy Indian Pharma Needs to Enable Managers to Develop Talent
Why Indian Pharma Needs to Enable Managers to Develop TalentAnup Soans
 
Digital Excellence Pharma Academy Certification Program
Digital Excellence Pharma Academy Certification ProgramDigital Excellence Pharma Academy Certification Program
Digital Excellence Pharma Academy Certification ProgramAnup Soans
 
Digital Excellent Pharma Academy Certification Program
Digital Excellent Pharma Academy Certification ProgramDigital Excellent Pharma Academy Certification Program
Digital Excellent Pharma Academy Certification ProgramAnup Soans
 
COVID-19 Vaccine Roll Out Plan by Ministry of Health and Family Affairs
COVID-19 Vaccine Roll Out Plan by Ministry of Health and Family AffairsCOVID-19 Vaccine Roll Out Plan by Ministry of Health and Family Affairs
COVID-19 Vaccine Roll Out Plan by Ministry of Health and Family AffairsAnup Soans
 
Architecture To Develop Pharma Business Leaders For Today and Tomorrow
Architecture To Develop Pharma Business Leaders  For Today and Tomorrow  Architecture To Develop Pharma Business Leaders  For Today and Tomorrow
Architecture To Develop Pharma Business Leaders For Today and Tomorrow Anup Soans
 
What is Indian Pharma Thinking about Digital? A Research Project
What is Indian Pharma Thinking about Digital? A Research ProjectWhat is Indian Pharma Thinking about Digital? A Research Project
What is Indian Pharma Thinking about Digital? A Research ProjectAnup Soans
 
Digital Excellence Pharma Academy - Webinar & Online Certification Program
Digital Excellence Pharma Academy - Webinar & Online Certification ProgramDigital Excellence Pharma Academy - Webinar & Online Certification Program
Digital Excellence Pharma Academy - Webinar & Online Certification ProgramAnup Soans
 
Telemedicine Guidelines for Indian Doctors
Telemedicine Guidelines for Indian DoctorsTelemedicine Guidelines for Indian Doctors
Telemedicine Guidelines for Indian DoctorsAnup Soans
 
The Mankind Pharma Story by Dr. Sumit Ghoshal
The Mankind Pharma Story by Dr. Sumit GhoshalThe Mankind Pharma Story by Dr. Sumit Ghoshal
The Mankind Pharma Story by Dr. Sumit GhoshalAnup Soans
 
Indian Pharma and Retail Pharmacies - Sales View Poll
Indian Pharma and Retail Pharmacies - Sales View PollIndian Pharma and Retail Pharmacies - Sales View Poll
Indian Pharma and Retail Pharmacies - Sales View PollAnup Soans
 
Healthcare's Future will be Patient Experience
Healthcare's Future will be Patient ExperienceHealthcare's Future will be Patient Experience
Healthcare's Future will be Patient ExperienceAnup Soans
 
Unethical Practices in Pharma - Interesting Study from Pakistan
Unethical Practices in Pharma - Interesting Study from Pakistan Unethical Practices in Pharma - Interesting Study from Pakistan
Unethical Practices in Pharma - Interesting Study from Pakistan Anup Soans
 
MedicinMan December 2018 Issue
MedicinMan December 2018 IssueMedicinMan December 2018 Issue
MedicinMan December 2018 IssueAnup Soans
 

Más de Anup Soans (20)

An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...
An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...
An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...
 
Key Challenges Facing Pharma Industry and the Way Forward
Key Challenges Facing Pharma Industry and the Way ForwardKey Challenges Facing Pharma Industry and the Way Forward
Key Challenges Facing Pharma Industry and the Way Forward
 
Trends in Pharma Marketing - Focus and Spending
Trends in Pharma Marketing - Focus and SpendingTrends in Pharma Marketing - Focus and Spending
Trends in Pharma Marketing - Focus and Spending
 
MedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27th
MedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27thMedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27th
MedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27th
 
Key Account Management - Time for India Pharma to Adopt KAM
Key Account Management - Time for India Pharma to Adopt KAMKey Account Management - Time for India Pharma to Adopt KAM
Key Account Management - Time for India Pharma to Adopt KAM
 
MedicinMan Report on Digital Readiness of Indian Pharma 2021
MedicinMan Report on Digital Readiness of Indian Pharma 2021MedicinMan Report on Digital Readiness of Indian Pharma 2021
MedicinMan Report on Digital Readiness of Indian Pharma 2021
 
How can Pharma Use Digital to Engage Doctors and Understand Patients
How can Pharma Use Digital to Engage Doctors and Understand PatientsHow can Pharma Use Digital to Engage Doctors and Understand Patients
How can Pharma Use Digital to Engage Doctors and Understand Patients
 
Why Indian Pharma Needs to Enable Managers to Develop Talent
Why Indian Pharma Needs to Enable Managers to Develop TalentWhy Indian Pharma Needs to Enable Managers to Develop Talent
Why Indian Pharma Needs to Enable Managers to Develop Talent
 
Digital Excellence Pharma Academy Certification Program
Digital Excellence Pharma Academy Certification ProgramDigital Excellence Pharma Academy Certification Program
Digital Excellence Pharma Academy Certification Program
 
Digital Excellent Pharma Academy Certification Program
Digital Excellent Pharma Academy Certification ProgramDigital Excellent Pharma Academy Certification Program
Digital Excellent Pharma Academy Certification Program
 
COVID-19 Vaccine Roll Out Plan by Ministry of Health and Family Affairs
COVID-19 Vaccine Roll Out Plan by Ministry of Health and Family AffairsCOVID-19 Vaccine Roll Out Plan by Ministry of Health and Family Affairs
COVID-19 Vaccine Roll Out Plan by Ministry of Health and Family Affairs
 
Architecture To Develop Pharma Business Leaders For Today and Tomorrow
Architecture To Develop Pharma Business Leaders  For Today and Tomorrow  Architecture To Develop Pharma Business Leaders  For Today and Tomorrow
Architecture To Develop Pharma Business Leaders For Today and Tomorrow
 
What is Indian Pharma Thinking about Digital? A Research Project
What is Indian Pharma Thinking about Digital? A Research ProjectWhat is Indian Pharma Thinking about Digital? A Research Project
What is Indian Pharma Thinking about Digital? A Research Project
 
Digital Excellence Pharma Academy - Webinar & Online Certification Program
Digital Excellence Pharma Academy - Webinar & Online Certification ProgramDigital Excellence Pharma Academy - Webinar & Online Certification Program
Digital Excellence Pharma Academy - Webinar & Online Certification Program
 
Telemedicine Guidelines for Indian Doctors
Telemedicine Guidelines for Indian DoctorsTelemedicine Guidelines for Indian Doctors
Telemedicine Guidelines for Indian Doctors
 
The Mankind Pharma Story by Dr. Sumit Ghoshal
The Mankind Pharma Story by Dr. Sumit GhoshalThe Mankind Pharma Story by Dr. Sumit Ghoshal
The Mankind Pharma Story by Dr. Sumit Ghoshal
 
Indian Pharma and Retail Pharmacies - Sales View Poll
Indian Pharma and Retail Pharmacies - Sales View PollIndian Pharma and Retail Pharmacies - Sales View Poll
Indian Pharma and Retail Pharmacies - Sales View Poll
 
Healthcare's Future will be Patient Experience
Healthcare's Future will be Patient ExperienceHealthcare's Future will be Patient Experience
Healthcare's Future will be Patient Experience
 
Unethical Practices in Pharma - Interesting Study from Pakistan
Unethical Practices in Pharma - Interesting Study from Pakistan Unethical Practices in Pharma - Interesting Study from Pakistan
Unethical Practices in Pharma - Interesting Study from Pakistan
 
MedicinMan December 2018 Issue
MedicinMan December 2018 IssueMedicinMan December 2018 Issue
MedicinMan December 2018 Issue
 

Indian Pharma Top 50 Companies - May 2014

  • 1. Val in Crs MAT MTH Val (Cr) MS% GR% Val (Cr) MS% GR% CORPORATE MAT MTH 76567 100.00 5.9 6636 100.00 8.1 IPM 1 1 4893 6.39 3.8 414 6.44 4.8 Abbott + Abbott HC + Novo `1 1 2 2 4168 5.44 15.4 377 5.34 15.2 Sun Pharma 2 2 3 3 3809 4.97 6.2 326 4.97 6.8 Cipla `2 3 4 4 3363 4.39 6.3 281 4.39 4.3 Zydus + Biochem 3 4 5 6 2836 3.70 -3.6 233 3.98 -4.7 Ranbaxy `3 7 6 5 2727 3.56 5.4 243 3.50 13.3 Mankind `5 9 7 8 2710 3.54 -15.6 227 4.02 -7.8 Glaxo 4 6 8 9 2673 3.49 9.9 226 3.39 8.3 Alkem + Cachet + Indchemie 5 8 9 7 2581 3.37 11.7 230 3.36 11.7 Lupin `4 5 10 11 2226 2.91 3.0 189 2.95 4.0 Pfizer 6 11 11 12 2162 2.82 15.0 183 2.65 12.9 Emcure + Zuventus `6 12 12 10 2056 2.69 11.5 198 2.55 26.7 Macleods 7 10 13 13 1926 2.52 0.3 175 2.65 7.7 Sanofi `7 13 14 14 1909 2.49 7.0 168 2.55 7.4 Intas 8 14 15 15 1877 2.45 14.7 164 2.17 23.1 Aristo `8 15 16 18 1667 2.18 15.7 131 1.89 13.6 Glenmark 9 18 17 16 1635 2.14 5.7 144 2.16 8.9 Dr. Reddys `9 16 18 17 1572 2.05 9.3 139 2.15 5.7 Micro + Bal 10 17 19 21 1407 1.84 9.1 118 1.87 3.1 USV `10 21 20 19 1394 1.82 14.0 127 1.79 15.1 Torrent 11 19 21 20 1372 1.79 20.4 124 1.59 27.8 IPCA `11 20 22 22 1222 1.60 3.0 102 1.53 8.6 Wockhardt 12 22 23 23 1133 1.48 -1.3 94 1.55 -1.4 Novartis `12 23 24 24 1056 1.38 10.5 86 1.23 13.4 Alembic 13 24 25 25 812 1.06 2.3 72 1.13 2.8 FDC `13 25 26 27 793 1.04 8.2 70 0.98 16.1 Unichem 14 27 27 26 784 1.02 7.7 70 0.95 19.6 MSD + Fulford + Organon `14 26 28 28 616 0.80 11.4 55 0.83 7.7 Cadila 15 28 29 29 592 0.77 5.3 50 0.72 13.2 Indoco Remedies 16 30 30 31 567 0.74 11.6 48 0.69 13.5 Franco `16 31 31 30 566 0.74 24.1 50 0.72 13.4 Eris `15 29 32 32 470 0.61 3.0 44 0.63 14.1 Himalaya 17 32 33 34 465 0.61 8.9 42 0.60 13.9 Merck `17 34 34 43 429 0.56 -41.4 30 0.97 -49.8 Elder 18 42 35 37 423 0.55 1.5 35 0.50 14.2 Blue Cross `19 37 36 33 405 0.53 11.0 43 0.65 6.8 JB Chemicals 19 33 37 40 395 0.52 16.7 32 0.51 0.9 Astrazeneca `18 39 38 39 383 0.50 -10.7 32 0.65 -19.7 Bharat Serums 20 40 39 36 376 0.49 -1.0 35 0.54 5.5 Raptakos, Brett `20 35 40 35 372 0.49 21.0 35 0.45 27.5 Meyer Organics 21 36 41 38 361 0.47 7.8 33 0.46 16.8 Wallace + Indi Pharma `21 38 42 45 347 0.45 11.6 28 0.39 17.0 Hetero `23 51 With Bonus Units at Full Value Witho Rank MAT May-14 May-14 Rank
  • 2. 43 42 333 0.43 7.6 30 0.44 10.4 Medley 23 43 44 44 330 0.43 0.6 29 0.45 3.3 Win-Medicare 22 44 45 41 318 0.41 33.4 31 0.33 54.1 Akumentis 24 41 46 48 317 0.41 10.8 27 0.41 8.1 Janssen `22 46 47 47 311 0.41 3.3 27 0.44 2.1 Albert David `24 47 48 50 293 0.38 47.9 26 0.30 44.8 Biocon 25 49 49 46 284 0.37 33.4 28 0.31 45.0 Ajanta `25 45 50 52 277 0.36 25.2 26 0.37 14.3 Hegde & Hegde 26 50
  • 3. Val (Cr) MS% GR% Val (Cr) MS% GR% 73629 100.00 5.9 6397 100.00 8.7 4794 6.51 3.5 407 6.36 5.2 4073 5.53 14.4 370 5.78 15.2 3572 4.85 9.0 307 4.80 10.3 3143 4.27 6.1 264 4.12 5.7 2743 3.73 -3.6 225 3.52 -4.7 2306 3.13 6.9 208 3.25 16.9 2675 3.63 -14.9 226 3.53 -6.2 2483 3.37 9.7 212 3.31 10.0 2524 3.43 11.6 226 3.53 12.1 2176 2.95 3.3 185 2.89 4.6 2097 2.85 15.3 178 2.78 13.5 1927 2.62 11.2 186 2.90 26.8 1890 2.57 0.0 172 2.68 7.6 1884 2.56 6.4 166 2.60 7.7 1654 2.25 11.9 143 2.23 20.5 1619 2.20 15.3 128 2.00 13.4 1602 2.18 4.9 141 2.21 8.8 1503 2.04 9.9 134 2.09 6.3 1401 1.90 9.0 118 1.84 3.4 1370 1.86 13.8 124 1.94 14.5 1305 1.77 20.0 120 1.87 29.4 1197 1.63 2.7 100 1.56 8.7 1092 1.48 -0.6 91 1.42 0.4 1023 1.39 11.0 83 1.30 14.3 790 1.07 2.2 69 1.08 3.2 776 1.05 7.5 68 1.06 16.1 774 1.05 7.6 69 1.07 18.8 594 0.81 11.2 53 0.83 7.6 551 0.75 5.6 47 0.73 13.4 546 0.74 11.0 46 0.72 13.3 563 0.76 23.9 50 0.77 13.3 468 0.64 2.6 44 0.68 13.8 454 0.62 7.5 41 0.64 12.6 413 0.56 -39.8 29 0.46 -47.7 389 0.53 3.5 32 0.50 13.5 389 0.53 10.8 41 0.64 6.1 391 0.53 15.8 31 0.49 0.5 375 0.51 -11.2 31 0.49 -19.9 371 0.50 -1.3 35 0.54 5.6 360 0.49 20.8 34 0.53 27.5 331 0.45 11.7 32 0.50 28.5 315 0.43 11.9 25 0.40 17.9 Without Bonus Units MAT May -14 May-14
  • 4. 316 0.43 8.3 29 0.45 10.3 325 0.44 -0.6 28 0.44 1.7 311 0.42 35.4 31 0.48 54.7 317 0.43 10.7 27 0.43 8.1 305 0.41 3.2 27 0.42 1.9 292 0.40 47.9 26 0.41 44.7 282 0.38 33.3 27 0.43 44.9 276 0.38 25.2 26 0.40 14.3